Canary Gold Corp. has appointed its President, Mark Tommasi, as an interim director following the recent resignation of board member Al Kanji. This move ensures continuity in corporate governance during the board transition period. Canary Gold is focused on gold exploration in Brazil, holding significant interests in the Rio Madeira Project and additional mineral tenements in Rondônia State. The appointment supports stable leadership as the company advances its regional exploration strategy.
Canary Gold Corp.'s interim director appointment provides context for readers interested in corporate governance changes. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 20, 2026 03:01 WIB: out of 83 priced US stocks, 34 rose and 48 fell. Notable movers include Calumet Inc. at USD 55.23 with a 1-day change of -4.36%, FMC Corp at USD 5.42 down 4.33%, and Sasol Ltd. at USD 15.72 down 3.79%.
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
